Farther Finance Advisors, LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in ARWR

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$750,581

-$42,181 QoQ

Shares Held

11,971

+0.3% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Farther Finance Advisors, LLC holds $14,686,998 across 278 Biotechnology names. ARWR ranks #6 (5.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,752	$2,121,958
2	REGN	Regeneron Pharmaceuticals, Inc.	1,870	$1,444,836
3	MRNA	Moderna, Inc.	20,211	$1,026,718
4	SMMT	Summit Therapeutics Inc.	50,316	$953,991
5	HALO	Halozyme Therapeutics, Inc.	13,333	$861,711
6	ARWR	Arrowhead Pharmaceuticals, Inc. This page	11,971	$750,581
7	EXEL	Exelixis, Inc.	16,443	$705,240
8	BMRN	Biomarin Pharmaceutical Inc	7,857	$443,841

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$750,581	11,971	+0.3%	Shares	Sole	2026-04-07
2025-12-31	$792,762	11,941	+2923.0%	Shares	Sole	2026-01-23
2025-09-30	$13,623	395	+758.7%	Shares	Sole	2025-10-14
2025-06-30	$726	46	-72.1%	Shares	Sole	2025-07-11
2025-03-31	$2,102	165	+275.0%	Shares	Sole	2025-04-14
2024-12-31	$827	44	-15.4%	Shares	Sole	2025-02-10
2024-09-30	$1,007	52	-73.7%	Shares	Sole	2024-10-29
2024-06-30	$5,146	198	-4.3%	Shares	Sole	2024-07-31
2024-03-31	$5,920	207	+2.5%	Shares	Sole	2024-05-14
2023-12-31	$6,181	202	+24.7%	Shares	Sole	2024-02-15
2023-06-30	$5,776	162	-14.3%	Shares	Sole	2024-05-14
2023-03-31	$4,800	189	+2600.0%	Shares	Sole	2024-05-14
2022-12-31	$283	7	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.